Using the industry peer median EV/Revenue multiple (trailing + forward), Pulse Biosciences, Inc. (PLSE) has a fair value of $1.19 based on 7 comparable companies in the Medical - Instruments & Supplies industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| Pulse Biosciences, Inc.PLSE | 1,615 | 4404.5x | 467.1x |
| Nektar Therapeutics | 1,992 | 38.5x | 51.2x |
| NovoCure Limited | 1,392 | 2.4x | 2.3x |
| Kestra Medical Technologies, Ltd. | 1,354 | 19.4x | 19.9x |
| STAAR Surgical Company | 1,234 | 4.7x | 3.6x |
| OPKO Health, Inc. | 937 | 1.6x | 1.8x |
| Beta Bionics, Inc. | 545 | 5.2x | 4.0x |
| LifeMD, Inc. | 217 | 1.0x | 0.9x |
| Industry Median | 4.7x | 3.6x | |
| (*) Revenue | 0 | 3 | |
| = Enterprise Value | 2 | 12 | |
| (-) Net Debt | -73 | -73 | |
| Equity Value | 75 | 85 | |
| (/) Outstanding shares | 67 | 67 | |
| Fair Price | $1 | $1 | |
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.